INDERAL LA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Inderal La, and what generic alternatives are available?
Inderal La is a drug marketed by Ani Pharms and is included in one NDA.
The generic ingredient in INDERAL LA is propranolol hydrochloride. There are twenty-two drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the propranolol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Inderal La
A generic version of INDERAL LA was approved as propranolol hydrochloride by INNOGENIX on October 22nd, 1985.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for INDERAL LA?
- What are the global sales for INDERAL LA?
- What is Average Wholesale Price for INDERAL LA?
Summary for INDERAL LA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 157 |
Clinical Trials: | 76 |
Patent Applications: | 3,873 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for INDERAL LA |
DailyMed Link: | INDERAL LA at DailyMed |
![INDERAL LA drug patent expirations Drug patent expirations by year for INDERAL LA](/p/graph/s/t/INDERAL_LA-patent-expirations.png)
![Drug Prices for INDERAL LA](/p/graph/drug-price/INDERAL+LA.png)
See drug prices for INDERAL LA
![Drug Sales Revenue Trends for INDERAL LA](/p/graph/drug-sales-revenues/INDERAL+LA.png)
Recent Clinical Trials for INDERAL LA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Zealand University Hospital | Phase 2 |
Rigshospitalet, Denmark | Phase 2 |
Second Xiangya Hospital of Central South University | Phase 1 |
Pharmacology for INDERAL LA
Drug Class | beta-Adrenergic Blocker |
Mechanism of Action | Adrenergic beta-Antagonists |
US Patents and Regulatory Information for INDERAL LA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ani Pharms | INDERAL LA | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 018553-004 | Mar 18, 1987 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Ani Pharms | INDERAL LA | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 018553-001 | Apr 19, 1983 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Ani Pharms | INDERAL LA | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 018553-002 | Apr 19, 1983 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Ani Pharms | INDERAL LA | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 018553-003 | Apr 19, 1983 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for INDERAL LA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ani Pharms | INDERAL LA | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 018553-004 | Mar 18, 1987 | ⤷ Sign Up | ⤷ Sign Up |
Ani Pharms | INDERAL LA | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 018553-003 | Apr 19, 1983 | ⤷ Sign Up | ⤷ Sign Up |
Ani Pharms | INDERAL LA | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 018553-001 | Apr 19, 1983 | ⤷ Sign Up | ⤷ Sign Up |
Ani Pharms | INDERAL LA | propranolol hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 018553-002 | Apr 19, 1983 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for INDERAL LA
See the table below for patents covering INDERAL LA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 510215 | ⤷ Sign Up | |
France | 2392667 | ⤷ Sign Up | |
Japan | S5459315 | PHARMACEUTICAL COMPOSITION WITH LONG LASTING DISCHARBABILITY | ⤷ Sign Up |
Switzerland | 638399 | PHARMAZEUTISCHES PRAEPARAT MIT VERZOEGERTER WIRKSTOFFABGABE. | ⤷ Sign Up |
Japan | S5740804 | ⤷ Sign Up | |
Sweden | 7806446 | ⤷ Sign Up | |
Germany | 2740286 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |